Show simple item record

dc.contributor.authorVaquer, Sergi
dc.contributor.authorCuyàs, Elisabet
dc.contributor.authorFenollosa i Artés, Felip
dc.contributor.authorDe la Torre Fornell, Rafael
dc.contributor.otherUniversitat Politècnica de Catalunya. Doctorat en Enginyeria Mecànica, Fluids i Aeronàutica
dc.identifier.citationVaquer, S. [et al.]. Active transmembrane drug transport in microgravity: A validation study using an ABC transporter model. "F1000 Research Ltd", 11 Desembre 2014, p. 1-15.
dc.description.abstractMicrogravity has been shown to influence the expression of ABC (ATP-Binding Cassette) transporters in bacteria, fungi and mammals, but also to modify the activity of certain cellular components with structural and functional similarities to ABC transporters. Changes in activity of ABC transporters could lead to important metabolic disorders and undesired pharmacological effects during spaceflights. However, no current means exist to study the functionality of these transporters in microgravity. To this end, a Vesicular Transport Assay® (Solvo Biotechnology, Hungary) was adapted to evaluate multi-drug resistance-associated protein 2 (MRP2) trans-membrane estradiol-17-ß-glucuronide (E17ßG) transport activity, when activated by adenosine-tri-phosphate (ATP) during parabolic flights. Simple diffusion, ATP-independent transport and benzbromarone inhibition were also evaluated. A high accuracy engineering system was designed to perform, monitor and synchronize all procedures. Samples were analysed using a validated high sensitivity drug detection protocol. Experiments were performed in microgravity during parabolic flights, and compared to 1g on ground results using identical equipment and procedures in all cases. Our results revealed that sufficient equipment accuracy and analytical sensitivity were reached to detect transport activity in both gravitational conditions. Additionally, transport activity levels of on ground samples were within commercial transport standards, proving the validity of the methods and equipment used. MRP2 net transport activity was significantly reduced in microgravity, so was signal detected in simple diffusion samples. Ultra-structural changes induced by gravitational stress upon vesicle membranes or transporters could explain the current results, although alternative explanations are possible. Further research is needed to provide a conclusive answer in this regard. Nevertheless, the present validated technology opens new and interesting research lines in biology and human physiology with the potential for significant benefits for both space and terrestrial medicine.
dc.format.extent15 p.
dc.rightsAttribution-BY 4.0 International
dc.subjectÀrees temàtiques de la UPC::Enginyeria mecànica
dc.subjectÀrees temàtiques de la UPC::Ciències de la salut::Medicina::Farmacologia
dc.subjectÀrees temàtiques de la UPC::Enginyeria biomèdica::Biomecànica
dc.subject.otherParabolic flight
dc.titleActive transmembrane drug transport in microgravity: A validation study using an ABC transporter model
dc.contributor.groupUniversitat Politècnica de Catalunya. TECNOFAB - Grup de Recerca en Tecnologies de Fabricació
dc.rights.accessOpen Access
dc.description.versionPostprint (published version)
local.citation.authorVaquer, S.; Cuyàs, E.; Fenollosa, F.; De la Torre, R.
local.citation.publicationNameF1000 Research Ltd

Files in this item


This item appears in the following Collection(s)

Show simple item record

Attribution 4.0 Generic
Except where otherwise noted, content on this work is licensed under a Creative Commons license : Attribution 4.0 Generic